These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23164464)

  • 1. Commentary on: Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chowdhury FU; Radhakrishna G; Godfrey EM
    Clin Radiol; 2013 Apr; 68(4):338-9. PubMed ID: 23164464
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
    Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of prognostic factors].
    Kessing R
    Rofo; 2013 Nov; 185(11):1028. PubMed ID: 24308049
    [No Abstract]   [Full Text] [Related]  

  • 4. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
    Sloof GW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
    McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM
    Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
    Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
    Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
    Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.
    Lindner K; Palmes D; Senninger N; Hummel R
    Langenbecks Arch Surg; 2015 Feb; 400(2):229-35. PubMed ID: 25572665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG Positron Emission Tomography and Computed Tomography Demonstration of Carcinoma Arising in an Epiphrenic Diverticulum.
    Eluvathingal Muttikkal TJ; Shami VM; Jones DR; Rehm PK
    J Radiol Case Rep; 2014 Nov; 8(11):42-6. PubMed ID: 25926910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous ovarian carcinoma detected on staging ¹⁸F-FDG PET/CT in a patient of esophageal carcinoma: a rare association.
    Mukherjee A; Sharma P; Karunanithi S; Jain S; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(5):308-9. PubMed ID: 25017383
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancer.
    Rankin S
    Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S156-60. PubMed ID: 22186083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
    Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
    Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.